O Yu-kyung, Director of MFDS, "Will Change Pharmaceutical Regulations to 'Global Standard'"

Visit to Hanmi Pharmaceutical Research Center

Oh Yu-kyung, Commissioner of the Ministry of Food and Drug Safety, is speaking at a meeting with pharmaceutical and bio industry officials on the 15th.
[Photo by Ministry of Food and Drug Safety]

Oh Yu-kyung, Commissioner of the Ministry of Food and Drug Safety (MFDS), who met with the pharmaceutical and bio industry, emphasized strengthening global competitiveness through bold regulatory innovation.

On the 15th, at Hanmi Pharmaceutical Research Center in Hwaseong, Gyeonggi Province, Commissioner Oh stated at a New Year's meeting with representatives of pharmaceutical companies, "We plan to boldly change Korea's pharmaceutical regulations to global standards so that domestic companies can enter and compete in overseas markets."

This meeting was organized to introduce the MFDS's major policy directions and key brand project plans in the pharmaceutical and biopharmaceutical sectors for this year, and to discuss future development and regulatory innovation measures together with the industry. Attendees included representatives from the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, Korea Drug Importers and Exporters Association, Korea Global Pharmaceutical Industry Association, Korea Biopharmaceutical Association, Hanmi Pharmaceutical, Dasan Pharmaceutical, Daewoong Pharmaceutical, Amgen Korea, Inist ST, Pfizer Korea, Huons, Hugel, and other associations and companies.

Commissioner Oh expressed gratitude for the efforts of industry officials who are leading the development of the domestic pharmaceutical industry and enhancing its international status, saying, "The MFDS will also do its best in improving pharmaceutical systems and providing administrative support," and added, "Please continue to strive to develop world-class high-quality innovative new drugs to improve public health and open new treatment opportunities for our people."

Before the meeting, Commissioner Oh encouraged Hanmi Pharmaceutical employees who received the first FDA approval for a new anticancer drug in Korea and inspected the research facilities.

This content was produced with the assistance of AI translation services.